SCHEMBL3681307

SCHEMBL3681307

C[N+]1(Cc2ccccc2)CCCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 6/20 0.60
CHRNB2 P17787 2/20 0.58
CHRNA4 P43681 2/20 0.58
APOBEC3A P31941 2/20 0.46
APOBEC3G Q9HC16 2/20 0.46
PABPC1 P11940 1/20 0.46
EIF4H Q15056 1/20 0.46
KDM4E B2RXH2 1/20 0.44
CTDSP1 Q9GZU7 1/20 0.44
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 1/20 0.43
CHRM3 P20309 2/20 0.42
CYP2D6 P10635 1/20 0.42
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM1 P11229 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10256901 0.98 CHRNB2 (0.61) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Iodide SCHEMBL3691022 0.98 CHRNA7 (0.63) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Hydrochloric Acid SCHEMBL2458828 0.98 CHRNA7 (0.58) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Water SCHEMBL3683454 0.98 CHRNA7 (0.58) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
SCHEMBL724930 0.98 CHRNB2 (0.61) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Water SCHEMBL8939227 0.96 CHRNB2 (0.59) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Bromide SCHEMBL2450495 0.96 CHRNB2 (0.59) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Hydrochloric Acid SCHEMBL723900 0.96 CHRNB2 (0.59) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Iodide SCHEMBL11507837 0.96 CHRNB2 (0.65) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G
Water SCHEMBL723735 0.96 CHRNB2 (0.59) CHRNA7CHRNB2CHRNA4APOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10836874-B2 High performance cross-linked triblock cationic functionalized polymer for electrochemical applications, methods of making and methods of using COLORADO SCHOOL OF MINES (US) 2020-11-17 US claimed
US-20190100633-A1 HIGH PERFORMANCE CROSS-LINKED TRIBLOCK CATIONIC FUNCTIONALIZED POLYMER FOR ELECTROCHEMICAL APPLICATIONS, METHODS OF MAKING AND METHODS OF USING UNIVERSITY OF MASSACHUSETTS 2019-04-04 US claimed
US-20100168490-A1 METHOD FOR PREPARATION OF AN ALUMINOSILICATE WITH FERRIERITE STRUCTURE FROM GELS CONTAINING TETRAMETHYLAMMONIUM AND BENZYLMETHYLPYRROLIDINE, AND USES THEREOF CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2010-07-01 US claimed
EP-2133309-A1 METHOD FOR PREPARATION OF AN ALUMINOSILICATE WITH FERRIERITE STRUCTURE FROM GELS CONTAINING TETRAMETHYL AMMONIUM AND BENZYLMETHYLPYRROLIDINE, AND USES THEREOF Consejo Superior De Investigaciones Científicas (ES) 2009-12-16 EP claimed
US-12555818-B2 Anode-less lithium ion battery SYENSQO SA (BE) 2026-02-17 US disclosed
EP-4622743-A1 SYNTHESIS OF A HIGH PURITY IZM-8 ZEOLITE OF FER FRAMEWORK TYPE IFP Energies nouvelles (FR) 2025-10-01 EP disclosed
US-20250201928-A1 LIQUID ELECTROLYTE FOR LITHIUM METAL BATTERIES SYENSQO SA (BE) 2025-06-19 US disclosed
CN-114930568-B Electrochemical device with at least one gelled electrode 西恩斯科公司 2025-06-10 CN disclosed
EP-4264709-B1 ELECTROLYTE COMPOSITION FOR LITHIUM METAL BATTERIES SYENSQO SA (BE) 2025-03-19 EP disclosed
US-12136744-B2 Hybrid fluoropolymer electrolyte membrane SYENSQO SA (BE) 2024-11-05 US disclosed
CN-118843965-A Liquid electrolyte for lithium metal battery 西恩斯科公司 2024-10-25 CN disclosed
US-20240243364-A1 LIQUID ELECTROLYTE FOR LITHIUM SECONDARY BATTERIES SOLVAY SA (BE) 2024-07-18 US disclosed
US-20090247674-A1 Polyester polyol and polyurethane resin DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2009-10-01 US disclosed
EP-1921101-A1 POLYESTER POLYOL AND POLYURETHANE RESIN DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2008-05-14 EP disclosed
US-7312208-B2 Quaternary ammonium compounds ASAHI KASEI PHARMA CORPORATION (JP) 2007-12-25 US disclosed
US-20070203115-A1 Novel quaternary ammonium compounds ASAHI KASEI PHARMA CORPORATION (JP) 2007-08-30 US disclosed
US-20070190041-A1 Novel benzothiazepine and bensothiepine compounds ASHAI KASEI PHARAMA CORPORATION (JP) 2007-08-16 US disclosed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 WO disclosed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 WO disclosed
US-20060186419-A1 Light-emitting device KABUSHIKI KAISHA TOSHIBA (JP) 2006-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12555818-B2 Anode-less lithium ion battery CACNA2D2, SLC9A2, CACNA2D1 CHRNA7 1147/4885CHRNB2 287/4885CHRNA4 728/4885
US-20070203115-A1 Novel quaternary ammonium compounds SLC10A2, SLC10A1, ABCB11 CHRNA7 3399/4885CHRNB2 2528/4885CHRNA4 3536/4885
US-20070190041-A1 Novel benzothiazepine and bensothiepine compounds SLC10A1, GOT1, CES1 CHRNA7 3152/4885CHRNB2 4564/4885CHRNA4 3309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.